S068 Skinternal Medicine: An Update on Cutaneous Manifestations of Systemic Disease
DESCRIPTION
This is a case-based discussion of complex dermatologic problems that have systemic implications. We will utilize an Audience Response System for this session and therefore, Handouts will NOT be provided prior to the session. Speakers will be asked to upload a handout after the session. This activity has been approved by the American Board of Dermatology for up to 3 hours of its Continuing Certification Program (CCP) Component 2 Self-Assessment points. For more information about CCP, please visit the ABD website at www.abderm.org
LEARNING OBJECTIVES
Diagnose skin diseases that are associated with internal manifestations more effectively.
Develop an appropriate, yet cost effective, method of evaluation for patient with complex medical/dermatological disease.
Formulate an evidence-based management plan for patients with complex medical/dermatological disease.
SCHEDULE
1:00 PM
Introduction
Jeffrey Phillip Callen, MD, FAAD
1:05 PM
Case 1
Joseph L. Jorizzo, MD, FAAD
1:20 PM
Case 2
Katharina Stephanie Shaw, MD, FAAD
1:35 PM
Case 3
Kanade Shinkai, MD, PhD, FAAD
1:50 PM
Q&A
Joseph L. Jorizzo, MD, FAAD, Katharina Stephanie Shaw, MD, FAAD, Kanade Shinkai, MD, PhD, FAAD
2:00 PM
Case 4
Jennifer Yeh, MD, PhD, FAAD
2:15 PM
Case 5
Frank Wang, MD, FAAD
2:30 PM
Case 6
Courtney Reynolds Schadt, MD, FAAD
2:45 PM
Q&A
Courtney Reynolds Schadt, MD, FAAD, Frank Wang, MD, FAAD, Jennifer Yeh, MD, PhD, FAAD
2:55 PM
Case 7
Jean L Bolognia, MD, FAAD
3:10 PM
Case 8
Andrea Maderal, MD, FAAD
3:25 PM
Case 9
Lindsay Chaney Strowd, MD, FAAD
3:40 PM
Case 10
Anthony Fernandez, MD, FAAD
3:55 PM
Q&A
Jean L Bolognia, MD, FAAD, Anthony Fernandez, MD, FAAD, Andrea Maderal, MD, FAAD, Lindsay Chaney Strowd, MD, FAAD
DIRECTOR
Jeffrey Phillip Callen, MD, FAAD
SPEAKERS
Jean L Bolognia, MD, FAAD
Anthony Fernandez, MD, FAAD
Joseph L. Jorizzo, MD, FAAD
Andrea Maderal, MD, FAAD
Courtney Reynolds Schadt, MD, FAAD
Katharina Stephanie Shaw, MD, FAAD
Kanade Shinkai, MD, PhD, FAAD
Lindsay Chaney Strowd, MD, FAAD
Frank Wang, MD, FAAD
Jennifer Yeh, MD, PhD, FAAD
DISCLOSURES
Jean L Bolognia, MD, FAAD
Elsevier Inc. – Other(Patent royalties or other compensation for Intellectual Property Rights);
Jeffrey Phillip Callen, MD, FAAD
3M Pharmaceuticals – Stockholder Public Company(No Compensation Received); Abbott Laboratories – Stockholder Public Company(No Compensation Received); AbbVie – Stockholder Public Company(No Compensation Received); Allergan, Inc – Stockholder Public Company(No Compensation Received); Amgen – Stockholder Public Company(No Compensation Received); Biogen – Data Safety Monitoring Board(Honoraria); Celgene – Stockholder Public Company(No Compensation Received); Elsevier Inc. – Other(Other Financial Benefit); JAMA – Other(No Compensation Received); Johnson and Johnson – Stockholder Public Company(No Compensation Received); Merck & Co., Inc – Stockholder Public Company(No Compensation Received); Pfizer Inc. – Stockholder Public Company(No Compensation Received); Procter & Gamble Company – Stockholder Public Company(No Compensation Received); Proivant – Data Safety Monitoring Board(Fees); UpToDate, Inc. – Other(Honoraria);
Anthony Fernandez, MD, FAAD
Amgen – Speaker(Honoraria); Astra Zeneca – Investigator(Grants/Research Funding); Biogen – Advisory Board(Honoraria), Consultant(Honoraria); Boehringer Ingelheim – Investigator(Grants/Research Funding); Castle Biosciences, Inc – Investigator(Grants/Research Funding); EMD Serono – Investigator(Grants/Research Funding); Galderma – Consultant (1099 relationship)(Honoraria), Speaker(Honoraria); Incyte – Investigator(Grants/Research Funding); Johnson & Johnson – Advisory Board(Honoraria); Mallinckrodt Pharmaceuticals – Consultant (1099 relationship)(Honoraria), Speaker(Honoraria); Merck & Co., Inc – Consultant (1099 relationship)(Honoraria); Pfizer Inc. – Consultant (1099 relationship)(Honoraria), Investigator(Grants/Research Funding); Priovant – Investigator(Grants/Research Funding); Priovant Therapeutics – Advisory Board(Honoraria); Sanofi/Regeneron – Consultant (1099 relationship)(Honoraria); Takeda Pharmaceuticals USA Inc – Advisory Board(Honoraria); UCB – Consultant(Honoraria);
Joseph L. Jorizzo, MD, FAAD
No financial relationships exist with ineligible companies.
Andrea Maderal, MD, FAAD
argenx – Consultant (1099 relationship)(Fees); Biogen – Investigator(Other Financial Benefit); Johnson and Johnson – Advisory Board(Fees); Medicines Development for Global Health – Data Safety Monitoring Board(Honoraria);
Courtney Reynolds Schadt, MD, FAAD
No financial relationships exist with ineligible companies.
Katharina Stephanie Shaw, MD, FAAD
Priovant – Employee (w-2 relationship)(Salary);
Kanade Shinkai, MD, PhD, FAAD
No financial relationships exist with ineligible companies.
Lindsay Chaney Strowd, MD, FAAD
Eli Lilly and Company – Advisory Board(Fees);
Frank Wang, MD, FAAD
Allergan – Investigator(Grants/Research Funding); ET Browne Drug Co Inc – Investigator(Grants/Research Funding); Galderma – Investigator(Grants/Research Funding); Linkou Chang Gung Memorial Hospital (Taiwan) – Investigator(Grants/Research Funding);
Jennifer Yeh, MD, PhD, FAAD
No financial relationships exist with ineligible companies.